Science
Mechanism of Action
This peptide operates by modulating progerin, a protein linked to cellular aging, thereby reducing its synthesis. It actively preserves the skin's structural integrity by inhibiting matrix metalloproteinases (MMPs) and elastase, which are enzymes responsible for degrading collagen and elastin. Additionally, Trifluoroacetyl Tripeptide-2 promotes the synthesis of extracellular matrix (ECM) components, stimulates syndecan production to prolong cell lifespan and enhance self-repair capabilities, and improves cellular communication to boost fibroblast activity. It also strengthens the skin barrier by stimulating the production of barrier lipids and proteins like filaggrin, leading to improved hydration and reduced transepidermal water loss, with a potential to inhibit tyrosinase activity for melanin reduction.
Research
Clinical Evidence
High confidence2%
Key findings
- 01 A 2% topical cream demonstrated significant improvements in vivo, showing up to a 10% lift in sagging jawline over 56 days, coupled with approximately 20% improvement in skin elasticity and firmness within 28 days.
- 02 In vivo studies reported a measurable reduction in jawline volume by 0.6% after 4 weeks and 3.4% after 8 weeks (p < 0.05 vs baseline and placebo). Cutaneous firmness improved by 20.0% (p < 0.1), elasticity by 20.9% (p < 0.1), and visco-elasticity by 13.3% (p < 0.01).
- 03 Additional clinical trials revealed notable reductions in wrinkle depth, skin roughness, and general sagging, supported by histological analysis showing increased collagen and elastin fiber density, and enhanced skin barrier function reducing moisture loss.
Transparency
Dusting Analysis
Effective concentrations for Trifluoroacetyl Tripeptide-2 in clinical applications range from 0.1% to 2%. Formulations containing less than 0.1% of this active ingredient may not deliver the expected clinical benefits and could be considered underdosed.
The Formula
Formulation
Stability
This peptide is stable in aqueous solutions. To maximize its stability and efficacy, it should be incorporated into formulations during the final manufacturing stage at temperatures not exceeding 40 °C.
Safety
Safety Profile
Trifluoroacetyl Tripeptide-2 is generally considered safe for topical cosmetic application, exhibiting a low irritancy profile. However, the Cosmetic Ingredient Review (CIR) Expert Panel has not conducted a formal review. Data regarding its topical use during pregnancy and breastfeeding are currently insufficient, therefore, consultation with a healthcare professional is advised for expectant or nursing individuals. The Environmental Working Group (EWG) assigns a moderate safety rating, citing general concerns about cancer, allergies, and developmental/reproductive toxicity, and classifies it as a PFAS, which prevents its inclusion in EWG VERIFIED products. A chemical safety assessment for research use indicates 'no hazard' classification according to GHS, though it is slightly hazardous for water.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Trifluoroacetyl Tripeptide-2 is a highly valuable anti-aging peptide, demonstrating significant clinical efficacy in improving skin firmness, elasticity, and reducing the visible signs of aging by targeting fundamental cellular and structural mechanisms.
Related
Similar Ingredients
Finding similar ingredients…